| 注册
首页|期刊导航|实用心电与临床诊疗|灯盏花素联合左卡尼汀治疗急性病毒性心肌炎效果分析

灯盏花素联合左卡尼汀治疗急性病毒性心肌炎效果分析

杜艳丽 董素英 尚祎 王庆浩

实用心电与临床诊疗2025,Vol.34Issue(2):171-175,5.
实用心电与临床诊疗2025,Vol.34Issue(2):171-175,5.DOI:10.13308/j.issn.2097-5716.2025.02.004

灯盏花素联合左卡尼汀治疗急性病毒性心肌炎效果分析

Therapeutic effect analysis of breviscapine combined with levocarnitine in patients with acute viral myocarditis

杜艳丽 1董素英 1尚祎 1王庆浩1

作者信息

  • 1. 461000 河南 许昌,许昌市人民医院心血管监护病房
  • 折叠

摘要

Abstract

Objective To observe the efficacy of breviscapine combined with levocarnitine in the treatment of patients with acute viral myocarditis(AVM),and analyze its impact on cardiac function and myocardial injury.Methods Clinical data of 96 patients with AVM were retrospectively analyzed.These patients were divided into a levocarnitine group and a combination group according to the treatment plan,with 48 cases in each group.In addition to conventional therapy received by patients in both groups,the levocarnitine group received levocarnitine treatment,while the combination group received intravenous infusion therapy with breviscapine combined with levocarnitine.Both groups received continuous medication administration for 14 days.The efficacy and adverse reactions between the two groups were compared,as well as cardiac function indexes[LVEF,stroke volume(SV)and cardiac output(CO)],myocardial injury markers[cTn I,creatine kinase MB(CK-MB),lactate dehydrogenase(LDH),aspartate aminotransferase(AST)and creatine kinase],inflammatory factors,and oxidative stress indicator levels before and after treatment.Results The total effective rate of the combination group was higher than that of the levocarnitine group(91.67%vs.70.83%,P<0.05).Compared with the levocarnitine group,the LVEF,SV and CO in the combination group were increased after treatment;serum cTn I,CK-MB,LDH,AST,creatine kinase,interleukin-6 and tumor necrosis factor-α(TNF-α)levels in the combination group after treatment were reduced,while the level of interleukin-4 was increased(all P<0.05).Compared with the levocarnitine group,serum superoxide dismutase(SOD)level in the combination group increased,while the advanced oxidation protein products(AOPP)and malondialdehyde levels reduced after treatment(all P<0.05).There was no statistically significant difference in the incidence of adverse reactions between the two groups(P>0.05).Conclusion Breviscapine combined with levocarnitine could significantly improve the therapeutic effect on AVM patients,significantly ameliorate cardiac function,which may be related to the inhibition of inflammation-oxidative stress response,and has good safety.

关键词

急性病毒性心肌炎/灯盏花素/左卡尼汀/疗效/心功能

Key words

acute viral myocarditis/breviscapine/levocarnitine/therapeutic effect/cardiac function

分类

临床医学

引用本文复制引用

杜艳丽,董素英,尚祎,王庆浩..灯盏花素联合左卡尼汀治疗急性病毒性心肌炎效果分析[J].实用心电与临床诊疗,2025,34(2):171-175,5.

实用心电与临床诊疗

2095-9354

访问量0
|
下载量0
段落导航相关论文